HU-308– synthetic, CB2 agonist


HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.                      (full – 1999)


Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2005)  cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW  CIT


Peripheral cannabinoid receptor, CB2, regulates bone mass                     (full – 2005)


Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.  (abst – 2005)                                         


Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2006)                                 









Activation of CB2 receptor attenuates bone loss in osteoporosis                       (news – 2006)


Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

(full – 2007)               


Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher       (interview – 2007)



Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor                                                              (full – 2008)  ulltext=cannabinoid&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT


Gadolinium-HU-308-incorporated micelles.                      (full – 2011)


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                               


CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling          (abst – 2011)


Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury.      (abst – 2011)                      


Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis                                                            (full – 2012)


Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects. (abst – 2012)


Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle                                                                         (abst – 2012)


Share a link for